Relapsed plasmablastic lymphoma in a HIV‐negative patient: Pushing the envelope

This case emphasizes that, with the availability of novel immunotherapy agents (Daratumumab), and repurposed use of bortezomib, a patient with HIV‐negative relapsed PBL can be treated successfully and consolidated with an allogeneic haploidentical hematopoietic cell transplantation.

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Case Rep
Egile Nagusiak: Kathrotiya, Manthan, Radhakrishnan, Vivek S, Bhave, Saurabh J, Kumar, Jeevan, Roychowdhury, Mita, Arun, Indu, Das, Jayanta, Chandy, Mammen, Nair, Reena
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Case Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869339/
https://ncbi.nlm.nih.gov/pubmed/33598263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3673
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak